160 related articles for article (PubMed ID: 32528470)
1. A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors.
Tobias J; Battin C; De Sousa Linhares A; Lebens M; Baier K; Ambroz K; Drinić M; Högler S; Inic-Kanada A; Garner-Spitzer E; Preusser M; Kenner L; Kundi M; Zielinski CC; Steinberger P; Wiedermann U
Front Immunol; 2020; 11():895. PubMed ID: 32528470
[TBL] [Abstract][Full Text] [Related]
2. Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways.
Cecil D; Park KH; Curtis B; Corulli L; Disis MN
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762321
[TBL] [Abstract][Full Text] [Related]
3. Immunogenic HER-2/neu peptides as tumor vaccines.
Baxevanis CN; Sotiriadou NN; Gritzapis AD; Sotiropoulou PA; Perez SA; Cacoullos NT; Papamichail M
Cancer Immunol Immunother; 2006 Jan; 55(1):85-95. PubMed ID: 15948002
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic Inhibition of FGFR Modulates the Metastatic Immune Microenvironment and Promotes Response to Immune Checkpoint Blockade.
Akhand SS; Liu Z; Purdy SC; Abdullah A; Lin H; Cresswell GM; Ratliff TL; Wendt M
Cancer Immunol Res; 2020 Dec; 8(12):1542-1553. PubMed ID: 33093218
[TBL] [Abstract][Full Text] [Related]
5. Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models.
Lu X; Deng S; Xu J; Green BL; Zhang H; Cui G; Zhou Y; Zhang Y; Xu H; Zhang F; Mao R; Zhong S; Cramer T; Evert M; Calvisi DF; He Y; Liu C; Chen X
J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37040183
[TBL] [Abstract][Full Text] [Related]
6. Targeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development.
Ma Y; Xiang D; Sun J; Ding C; Liu M; Hu X; Li G; Kloecker G; Zhang HG; Yan J
J Immunol; 2013 Jun; 190(11):5588-99. PubMed ID: 23630363
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models.
Karoon Kiani F; Izadi S; Ansari Dezfouli E; Ebrahimi F; Mohammadi M; Chalajour H; Mortazavi Bulus M; Nasr Esfahani M; Karpisheh V; Mahmoud Salehi Khesht A; Abbaszadeh-Goudarzi K; Soleimani A; Gholizadeh Navashenaq J; Ahmadi M; Hassannia H; Hojjat-Farsangi M; Shahmohammadi Farid S; Hashemi V; Jadidi-Niaragh F
Life Sci; 2022 Jan; 288():120166. PubMed ID: 34813798
[TBL] [Abstract][Full Text] [Related]
8. Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence.
Huemer F; Leisch M; Geisberger R; Melchardt T; Rinnerthaler G; Zaborsky N; Greil R
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325898
[TBL] [Abstract][Full Text] [Related]
9. Identification of Enhanced Vaccine Mimotopes for the p15E Murine Cancer Antigen.
Zhou S; Song Y; Luo Y; Quinn B; Jiao Y; Long MD; Abrams SI; Lovell JF
Cancer Res Commun; 2024 Apr; 4(4):958-969. PubMed ID: 38506662
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumorous Circ-E-Cadherinencoded C-E-Cad inhibits the recruitment and function of breast cancer-associated myeloid-derived suppressor cells.
Zhou J; Xu H; Li X; Liu H; Sun Z; Li J; Tang Y; Gao H; Zhao K; Ding C; Gao X
Pharmacol Res; 2024 Jun; 204():107204. PubMed ID: 38704109
[TBL] [Abstract][Full Text] [Related]
11. Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports study.
Mordoh J; Schwab E; Bravo AI; Aris M; Barrio MM
Front Immunol; 2024; 15():1354710. PubMed ID: 38726010
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of Ch806 mimotopes.
Yang L; Jiang H; Shi B; Wang H; Li J; Wang H; Yao M; Li Z
Cancer Immunol Immunother; 2010 Oct; 59(10):1481-7. PubMed ID: 20544195
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response.
Xu L; Saunders K; Huang SP; Knutsdottir H; Martinez-Algarin K; Terrazas I; Chen K; McArthur HM; Maués J; Hodgdon C; Reddy SM; Roussos Torres ET; Xu L; Chan IS
Cell Rep Med; 2024 May; 5(5):101511. PubMed ID: 38614094
[TBL] [Abstract][Full Text] [Related]
14. A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast disease.
Disis ML; Gad E; Herendeen DR; Lai VP; Park KH; Cecil DL; O'Meara MM; Treuting PM; Lubet RA
Cancer Prev Res (Phila); 2013 Dec; 6(12):1273-82. PubMed ID: 24154719
[TBL] [Abstract][Full Text] [Related]
15. Genetic immunization against neu/erbB2 transgenic breast cancer.
Amici A; Venanzi FM; Concetti A
Cancer Immunol Immunother; 1998 Dec; 47(4):183-90. PubMed ID: 9875670
[TBL] [Abstract][Full Text] [Related]
16. Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodies.
Zhao X; Qian W; Hou S; Wu Y; Guo H; Xu J; Zhang D; Li J; Fu R; Xu M; Wang F
J Pharm Biomed Anal; 2024 Aug; 245():116185. PubMed ID: 38723556
[TBL] [Abstract][Full Text] [Related]
17. Antitumor vaccines: is it possible to prevent a tumor?
Lollini PL; Forni G
Cancer Immunol Immunother; 2002 Oct; 51(8):409-16. PubMed ID: 12202901
[TBL] [Abstract][Full Text] [Related]
18. Prediction of biomarkers and therapeutic combinations for anti-PD-1 immunotherapy using the global gene network association.
Wu CC; Wang YA; Livingston JA; Zhang J; Futreal PA
Nat Commun; 2022 Jan; 13(1):42. PubMed ID: 35013211
[TBL] [Abstract][Full Text] [Related]
19. Peptide vaccinations elicited strong immune responses that were reboosted by anti-PD1 therapy in a patient with myxofibrosarcoma.
Tsukahara T; Watanabe K; Murata K; Takahashi A; Mizushima E; Shibayama Y; Kameshima H; Hatae R; Ohno Y; Kawahara R; Murai A; Nakatsugawa M; Kubo T; Kanaseki T; Hirohashi Y; Terui T; Asanuma H; Hasegawa T; Sato N; Torigoe T
Cancer Immunol Immunother; 2020 Feb; 69(2):189-197. PubMed ID: 31853575
[TBL] [Abstract][Full Text] [Related]
20. Checkpoint Inhibitors and Their Application in Breast Cancer.
Bedognetti D; Maccalli C; Bader SB; Marincola FM; Seliger B
Breast Care (Basel); 2016 Apr; 11(2):108-15. PubMed ID: 27239172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
